Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines.
Abstract
Nitrogen-based heterocycles such as pyrazole, imidazole, 1,2,4-triazole, benzimidazole, and benzotriazole substituted fused pyran derivatives (6a–e, 8a–e, 10a–e, 12a–e,&14a–e) have been synthesized and tested for their in vitro anticancer efficacies against MCF7, A549, and HCT116 cancer cell lines. Among the compounds, 6e, 14b, and 8c were identified as the most potent against MCF7, A549, and HCT116, with IC50 values of 12.46 2.72 mM, 0.23 0.12 mM, and 7.58 1.01 mM, respectively. Further studies demonstrated that these compounds can change cellular and nuclear morphology and inhibit colony formation in the tested cancer cells. They also remarkably block/inhibit the cell cycle progression of cancer cells at various phases. DNA damage analysis and apoptosis studies revealed that these compounds have the potential to induce DNA double-strand breaks and apoptosis. In silico absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the potent compounds were assessed, revealing that all the compounds exhibited favorable pharmacokinetic and toxicological properties. The potent compounds identified from this study can be considered as a lead for further drug design and development.
Citations
-
3
CrossRef
-
0
Web of Science
-
3
Scopus
Authors (10)
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.1039/D4NJ00824C
- License
- open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
NEW JOURNAL OF CHEMISTRY
no. 48,
pages 8038 - 8054,
ISSN: 1144-0546 - Language:
- English
- Publication year:
- 2024
- Bibliographic description:
- Fabitha K., Kallingal A., Maciejewska N., Arya C. G., Chandrakanth M., Thomas N. M., Li Y., Gondru R., Munikumar M., Banothu J.: Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines.// NEW JOURNAL OF CHEMISTRY -Vol. 48,iss. 18 (2024), s.8038-8054
- DOI:
- Digital Object Identifier (open in new tab) 10.1039/d4nj00824c
- Sources of funding:
-
- Free publication
- Verified by:
- Gdańsk University of Technology
seen 59 times
Recommended for you
Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
- M. Niemira,
- B. Borowa-Mazgaj,
- S. B. Bader
- + 8 authors
H2AX phosphorylation, its role in DNA damage response and cancer therapy
- M. Podhorecka,
- A. Składanowski,
- P. Bożko